Published in J Neurol on October 15, 2007
Vertical supranuclear gaze palsy in Niemann-Pick type C disease. Neurol Sci (2012) 1.04
Neuroimaging in dementia. Semin Neurol (2008) 0.78
From mild ataxia to huntington disease phenocopy: the multiple faces of spinocerebellar ataxia 17. Case Rep Neurol Med (2014) 0.75
Writer's cramp in spinocerebellar ataxia Type 1. J Neurosci Rural Pract (2016) 0.75
A role for cerebellum in the hereditary dystonia DYT1. Elife (2017) 0.75
Early-onset SCA17 with 43 TBP repeats: expanding the phenotype? Neurol Sci (2011) 0.75
Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature. Brain Sci (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol (2004) 3.83
SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet (2001) 2.30
SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol (2004) 1.72
A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet (1999) 1.69
Molecular pathogenesis of spinocerebellar ataxias. Brain (2006) 1.59
Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol (2004) 1.58
Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol (1997) 1.56
Pathways to motor incoordination: the inherited ataxias. Nat Rev Neurosci (2004) 1.43
Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol (2003) 1.29
Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol (2002) 1.26
Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain (2003) 1.26
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
TATA-binding protein in neurodegenerative disease. Neuroscience (2005) 1.16
A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. J Neurol Neurosurg Psychiatry (1994) 1.12
CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain (2001) 1.08
Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet (2001) 1.08
Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol (1998) 1.08
Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet (2004) 1.05
Ocular motor abnormalities in Huntington's disease. Vision Res (1997) 1.04
Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol (2004) 1.03
"Cryptic" repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am J Hum Genet (1993) 1.01
Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes. BMC Med Genet (2005) 0.96
Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain (2006) 0.96
The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand (2005) 0.95
Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain (1997) 0.93
Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7. Ann Neurol (2001) 0.93
Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am J Hum Genet (1996) 0.92
Minimum prevalence of spinocerebellar ataxia 17 in the north east of England. J Neurol Sci (2005) 0.91
Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord (2005) 0.89
The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord (2006) 0.88
Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci (2003) 0.88
Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17? J Neurol (2003) 0.87
Comparison of oculomotor findings in the progressive ataxia syndromes. Brain (1994) 0.85
SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6. Eur J Hum Genet (2003) 0.81
Slow saccades and other eye movement disorders in spinocerebellar atrophy type 1. J Neurol (1997) 0.80
Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol (1999) 0.79
Electrophysiologic characterization in spinocerebellar ataxia 17. Neurology (2006) 0.79
Oculomotor testing in the differential diagnosis of degenerative ataxic disorders. Arch Neurol (1998) 0.78
Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia. Ann Neurol (2004) 0.77
Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm (Vienna) (2004) 0.76
Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease. Clin Genet (2004) 0.76
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia. J Neurol (2004) 0.76
CAG repeats in Restless Legs syndrome. Am J Med Genet B Neuropsychiatr Genet (2006) 0.75
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
How the probability of a false positive affects the value of DNA evidence. J Forensic Sci (2003) 3.17
Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet (2010) 2.66
Mitochondrial disorders. Brain (2004) 2.32
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke (2006) 2.11
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature (2012) 2.08
Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathog (2007) 1.97
On the value of probability for evaluating results of comparative pattern analyses. Forensic Sci Int (2013) 1.93
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet (2009) 1.79
Postinfectious neurologic syndromes: a prospective cohort study. Neurology (2013) 1.73
Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic Biol Med (2006) 1.73
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet (2012) 1.71
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci (2005) 1.68
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain (2008) 1.63
A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference. Exp Neurol (2009) 1.59
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2006) 1.56
Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology (2009) 1.56
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging (2005) 1.52
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol (2008) 1.51
Cause and course in a series of patients with sporadic chorea. J Neurol (2003) 1.51
Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A (2002) 1.39
Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol (2007) 1.38
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol (2007) 1.36
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis (2012) 1.35
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet (2008) 1.30
Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage (2009) 1.29
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol (2012) 1.29
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. J Mol Diagn (2004) 1.27
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain (2003) 1.26
Visual system involvement in patients with Friedreich's ataxia. Brain (2008) 1.25
Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics (2007) 1.25
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer (2005) 1.25
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet (2013) 1.23
Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum Mol Genet (2005) 1.23
Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2006) 1.23
The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol Neurodegener (2009) 1.23
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol (2008) 1.21
Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol (2010) 1.20
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci (2007) 1.20
Reply to Budowle, Ge, Chakraborty and Gill-King: use of prior odds for missing persons identifications. Investig Genet (2012) 1.19
Pleiotropic effects of spastin on neurite growth depending on expression levels. J Neurochem (2009) 1.18
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.17
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain (2008) 1.16
Depression comorbidity in spinocerebellar ataxia. Mov Disord (2011) 1.15
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol (2008) 1.13
Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis. Cerebellum (2008) 1.13
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet (2007) 1.13
Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen (2009) 1.12
Frataxin, iron-sulfur clusters, heme, ROS, and aging. Antioxid Redox Signal (2006) 1.12
Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord (2006) 1.10
Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol (2009) 1.09
Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum Mol Genet (2003) 1.09
SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain (2005) 1.09
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2008) 1.08
The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation. Neurobiol Dis (2005) 1.08
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2007) 1.08
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord (2008) 1.06
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics (2005) 1.06
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet (2012) 1.05
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. Neurol Sci (2008) 1.04
Brain-derived neurotrophic factor in patients with Huntington's disease. PLoS One (2011) 1.04
Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol (2004) 1.03
Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci (2009) 1.03
Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia (2006) 1.03
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging (2004) 1.02
Schizencephaly: clinical spectrum, epilepsy, and pathogenesis. J Child Neurol (2005) 1.01
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Hum Genet (2006) 1.00
Frataxin gene point mutations in Italian Friedreich ataxia patients. Neurogenetics (2007) 1.00
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain (2013) 1.00
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry (2012) 1.00
The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet (2004) 0.99
A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle (2008) 0.98
Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration. Neurosci Lett (2006) 0.98
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.98